Skip to main content
Clinical Trials/NL-OMON50261
NL-OMON50261
Recruiting
Phase 4

Partial neuromuscular blockade to facilitate lung and diaphragm protective mechanical ventilation in ICU patients: A randomized controlled pilot study. - Partial neuromuscular blockade for lung protective mechanical ventilation

Vrije Universiteit Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Middenrif / longfunctie
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- high respiratory drive, defined as tidal volume \> 8ml/kg PBW on inspiratory
  • support of 12cmH2O.
  • \- sedation level: RASS \<\= \-3
  • \- ventilated in pressure support mode

Exclusion Criteria

  • \- recent use of NMBA (\<2 hrs)
  • \- arterial pH \<7\.25
  • \- hemodynamic instability, i.e. high dose vasopressors (\>0\.5 µg/kg/min) or
  • inotropes (dobutamine \>15 µg/kg/min or enoximone \>25 µg/kg/min)
  • \- intracranial pressure \>20 cmH2O
  • \- past medical history of neuromuscular disorders
  • \- pregnancy
  • \- known previous anaphylactic reaction to NMBA\*s.

Outcomes

Primary Outcomes

Not specified

Similar Trials